| Jeremy M Mason, DPM | |
|
10229 E 96th St N Suite 101, Owasso, OK 74055 | |
| (918) 272-8920 | |
| (918) 272-8922 |
| Full Name | Jeremy M Mason |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 19 Years |
| Location | 10229 E 96th St N Suite 101, Owasso, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710154471 | NPI | - | NPPES |
| 00256 | Other | OK | OKLAHOMA LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 00256 (Oklahoma) | Secondary |
| 213E00000X | Podiatrist | 256 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St John Owasso | Owasso, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro Tulsa Foot And Ankle Specialist Pllc | 1759293046 | 10 |
News Archive
Quick-Med Technologies, Inc. announced today the development of a new prototype wound dressing, NIMBUS® Advanced Active, developed as part of ongoing research currently being funded by the U.S. Army Medical Research and Material Command under a $900,000 Small Business Innovation Research (SBIR) grant. NIMBUS was competitively selected by the U.S. Army for evaluation in the healing of vesicant injuries, and this new dressing is the first "active" wound healing product developed by Quick-Med.
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose measurements in the eye in a live animal model.
A new robotic neck brace from researchers at Columbia Engineering and their colleagues at Columbia's Department of Otolaryngology may help doctors analyze the impact of cancer treatments on the neck mobility of patients and guide their recovery.
Health care professionals make calculated decisions daily to not alert their colleagues when a safety tool signals potential harm to a patient, according to a new study of 6,500 nurses and nurse managers released March 22 during a national briefing in Philadelphia.
A new study has shown that COVID-19 patients admitted to the Intensive care unit may be resistant to the naturally occurring anticoagulant Heparin. The study titled, "Heparin resistance in COVID‑19 patients in the intensive care unit," was published in the latest issue of the Journal of Thrombosis and Thrombolysis.
› Verified 5 days ago
| Provider Name | Metro Tulsa Foot & Ankle Specialist Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477588945 PECOS PAC ID: 1759293046 Enrollment ID: O20031104000660 |
News Archive
Quick-Med Technologies, Inc. announced today the development of a new prototype wound dressing, NIMBUS® Advanced Active, developed as part of ongoing research currently being funded by the U.S. Army Medical Research and Material Command under a $900,000 Small Business Innovation Research (SBIR) grant. NIMBUS was competitively selected by the U.S. Army for evaluation in the healing of vesicant injuries, and this new dressing is the first "active" wound healing product developed by Quick-Med.
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose measurements in the eye in a live animal model.
A new robotic neck brace from researchers at Columbia Engineering and their colleagues at Columbia's Department of Otolaryngology may help doctors analyze the impact of cancer treatments on the neck mobility of patients and guide their recovery.
Health care professionals make calculated decisions daily to not alert their colleagues when a safety tool signals potential harm to a patient, according to a new study of 6,500 nurses and nurse managers released March 22 during a national briefing in Philadelphia.
A new study has shown that COVID-19 patients admitted to the Intensive care unit may be resistant to the naturally occurring anticoagulant Heparin. The study titled, "Heparin resistance in COVID‑19 patients in the intensive care unit," was published in the latest issue of the Journal of Thrombosis and Thrombolysis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy M Mason, DPM 701 W. Elgin St, Broken Arrow, OK 74012 Ph: (918) 455-2001 | Jeremy M Mason, DPM 10229 E 96th St N Suite 101, Owasso, OK 74055 Ph: (918) 272-8920 |
News Archive
Quick-Med Technologies, Inc. announced today the development of a new prototype wound dressing, NIMBUS® Advanced Active, developed as part of ongoing research currently being funded by the U.S. Army Medical Research and Material Command under a $900,000 Small Business Innovation Research (SBIR) grant. NIMBUS was competitively selected by the U.S. Army for evaluation in the healing of vesicant injuries, and this new dressing is the first "active" wound healing product developed by Quick-Med.
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose measurements in the eye in a live animal model.
A new robotic neck brace from researchers at Columbia Engineering and their colleagues at Columbia's Department of Otolaryngology may help doctors analyze the impact of cancer treatments on the neck mobility of patients and guide their recovery.
Health care professionals make calculated decisions daily to not alert their colleagues when a safety tool signals potential harm to a patient, according to a new study of 6,500 nurses and nurse managers released March 22 during a national briefing in Philadelphia.
A new study has shown that COVID-19 patients admitted to the Intensive care unit may be resistant to the naturally occurring anticoagulant Heparin. The study titled, "Heparin resistance in COVID‑19 patients in the intensive care unit," was published in the latest issue of the Journal of Thrombosis and Thrombolysis.
› Verified 5 days ago
Timothy J Siegfried, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 10229 E 96th St N Suite 100, Owasso, OK 74055 Phone: 918-272-8920 Fax: 918-272-8922 | |
Metro Tulsa Foot & Ankle Specialists Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 10229 E 96th St N, Suite 100, Owasso, OK 74055 Phone: 918-272-8920 Fax: 918-272-8922 |